| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |